Literature DB >> 27623511

Pharmacokinetics and microbiodistribution of 64Cu-labeled collagen-binding peptides in chronic myocardial infarction.

Heejung Kim1, Sung-Jin Lee, Jin Su Kim, Cynthia Davies-Venn, Hong-Jun Cho, Samuel J Won, Eden Dejene, Zhengsheng Yao, Insook Kim, Chang H Paik, David A Bluemke.   

Abstract

OBJECTIVES: The aim of the study is to evaluate the pharmacokinetics and microbiodistribution of Cu-labeled collagen-binding peptides.
METHODS: The affinity constant (KD), association (ka), and dissociation rate constant (kd) for the peptide collagelin or its analog (named CRPA) binding to collagen were measured by biolayer interferometric analysis. Rats (n=4-5) with myocardial infarction or normal were injected intravenously with the Cu-labeled peptides or Cu-DOTA as a control. Dynamic PET imaging was performed for 60 min at 7-8 weeks after infarct. Fluorine-18 fluorodeoxyglucose PET imaging was performed to identify the viable myocardium. To validate the PET images, slices of heart samples from the base to the apex were analyzed using autoradiography and histology. RESULT: The peptides bound to collagen with a KD of ∼0.9 µmol/l. The Cu-peptides and Cu-DOTA accumulated in the infarct area (confirmed by autoradiography and histology images) within 1 min of injection and were excreted rapidly through the renal system. The blood clearance curves were biphasic with elimination half-lives of 21.9±2.4, 26.2±4.6, and 21.2±2.1 min for Cu-CRPA, Cu-collagelin, and the control Cu-DOTA, respectively. The clearance half-lives from the focal fibrotic tissue (24.1±1.5, 25.6±8.0, and 21.4±1.3 min, respectively) and remote myocardium (20.8±0.7, 21.0±5.5, and 19.1±2.4 min, respectively) were not significantly different. The uptake ratios of infarct-to-remote myocardium (1.93±0.18, 2.15±0.38, and 1.88±0.08, respectively) for Cu-CRPA, Cu-collagelin, and Cu-DOTA remained stable for the time period between 10 and 60 min.
CONCLUSION: The distribution of the Cu-collagelin probes corresponds to the heterogeneous distribution of expanded extracellular space in the setting of myocardial infarction. The overall washout rate from the fibrous tissue was determined by the slow washout rate (t1/2≥20 min) of the peptides from the extracellular space to the vasculature, not by the dissociation rate (t1/2<2 min) of the Cu-peptides from collagen.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27623511      PMCID: PMC5077647          DOI: 10.1097/MNM.0000000000000590

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  25 in total

1.  PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.

Authors:  Haokao Gao; Lixin Lang; Ning Guo; Feng Cao; Qimeng Quan; Shuo Hu; Dale O Kiesewetter; Gang Niu; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-25       Impact factor: 9.236

2.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Authors:  Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

3.  Synthesis and preclinical evaluation of 68Ga-labeled collagelin analogs for imaging and quantification of fibrosis.

Authors:  Irina Velikyan; Ulrika Rosenström; Sergio Estrada; Ingrid Ljungvall; Jens Häggström; Olof Eriksson; Gunnar Antoni
Journal:  Nucl Med Biol       Date:  2014-06-09       Impact factor: 2.408

4.  Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models.

Authors:  B I Jugdutt; M J Joljart; M I Khan
Journal:  Circulation       Date:  1996-07-01       Impact factor: 29.690

5.  Gd-DOTA: characterization of a new paramagnetic complex.

Authors:  J C Bousquet; S Saini; D D Stark; P F Hahn; M Nigam; J Wittenberg; J T Ferrucci
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

6.  Non-invasive imaging of glycoprotein VI binding to injured arterial lesions.

Authors:  Meinrad Gawaz; Ildiko Konrad; Andrea I Hauser; Suzanne Sauer; Zhongyan Li; Hans-Jürgen Wester; Frank M Bengel; Markus Schwaiger; Albert Schömig; Steffen Massberg; Roland Haubner
Journal:  Thromb Haemost       Date:  2005-05       Impact factor: 5.249

7.  Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent.

Authors:  Patrick A Helm; Peter Caravan; Brent A French; Vincent Jacques; Luhua Shen; Yaqin Xu; Ronald J Beyers; R Jack Roy; Christopher M Kramer; Frederick H Epstein
Journal:  Radiology       Date:  2008-04-10       Impact factor: 11.105

8.  Assessment of cardiovascular fibrosis using novel fluorescent probes.

Authors:  Jiqiu Chen; Seung Koo Lee; Wael R Abd-Elgaliel; Lifan Liang; Elisa-Yaniz Galende; Roger J Hajjar; Ching-Hsuan Tung
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

9.  Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.

Authors:  Peter Kellman; Joel R Wilson; Hui Xue; W Patricia Bandettini; Sujata M Shanbhag; Kirk M Druey; Martin Ugander; Andrew E Arai
Journal:  J Cardiovasc Magn Reson       Date:  2012-09-11       Impact factor: 5.364

10.  Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI.

Authors:  Julien Muzard; Laure Sarda-Mantel; Stéphane Loyau; Alain Meulemans; Liliane Louedec; Claudie Bantsimba-Malanda; Florence Hervatin; Joëlle Marchal-Somme; Jean Baptiste Michel; Dominique Le Guludec; Philippe Billiald; Martine Jandrot-Perrus
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more
  2 in total

1.  Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis.

Authors:  Frank M Bengel; Tobias L Ross
Journal:  J Nucl Cardiol       Date:  2018-07-02       Impact factor: 5.952

2.  Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice.

Authors:  Sadaf Aghevlian; Bo Wu; Marina Nura Raie; Spencer K Tumbale; Aris J Kare; Jai W Seo; Katherine W Ferrara
Journal:  Nucl Med Biol       Date:  2021-04-21       Impact factor: 2.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.